R.G.C.C Group + Banner

HOME PAGE
CURRENT FEATURES/Volume 3 Issue 3
EDITORIAL ARCHIVE
ARCHIVED ISSUES
EVENTS
COMPANY PROFILE
- A-D
- E-M
- N-S
- T-Z
SPONSORED ARTICLES
NEWS

HOME PAGE
CURRENT FEATURES/Volume 3 Issue 3
EDITORIAL ARCHIVE
ARCHIVED ISSUES
EVENTS
COMPANY PROFILE
- A-D
- E-M
- N-S
- T-Z
SPONSORED ARTICLES
NEWS
More

A-D

2 months ago-Diamond Pharma Services

2 years ago-Biopharma Group

Archive

Category: Volume 3 Issue 1

Building a better healthcare cluster

Building a better healthcare cluster

Volume 3 Issue 1 131 0

Unique Challenges and Opportunities in Orphan Diseases

Unique Challenges and Opportunities in Orphan Diseases

Volume 3 Issue 1 148 0

Geroscience and The Exposome

Geroscience and The Exposome

Volume 3 Issue 1 139 0

Betting on the Bug, Part III: Leveraging the Microbiome to Generate New Models

Betting on the Bug, Part III: Leveraging the Microbiome to Generate New Models

Volume 3 Issue 1 101 0

Mass Spectrometry Supports Development of New Oligonucleotide Therapeutics

Mass Spectrometry Supports Development of New Oligonucleotide Therapeutics

Volume 3 Issue 1 102 0

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Volume 3 Issue 1 96 0

Increasing Patient Access to Advanced Therapies; the UK Perspective

Increasing Patient Access to Advanced Therapies; the UK Perspective

Volume 3 Issue 1 102 0

The New Drugs and Clinical Trial Rules of India: A Regulatory Highlights

The New Drugs and Clinical Trial Rules of India: A Regulatory Highlights

Volume 3 Issue 1 100 0

Go-to-market Challenges of CAR-T Therapies

Go-to-market Challenges of CAR-T Therapies

Volume 3 Issue 1 117 0

Developing Plasmid DNA Production Platforms to Support Novel Gene Therapies

Developing Plasmid DNA Production Platforms to Support Novel Gene Therapies

Volume 3 Issue 1 105 0

Driving the Commercialisation of Regenerative Medicine

Driving the Commercialisation of Regenerative Medicine

Volume 3 Issue 1 136 0

How the Biopharmaceutical Industry is Responding to Patient Demand for Injection Alternatives

How the Biopharmaceutical Industry is Responding to Patient Demand for Injection Alternatives

Volume 3 Issue 1 461 0

ABOUT US
EDITORIAL GUIDELINES
- Peer-Review Protocol
- Author Guidelines
ADVERTISE WITH US
- Media Information 2021
- Media Information 2020
SUBSCRIBE
GDPR POLICY
CONTACT US

Bio Pharmaceutical Media © 2018 Powered by Teksyte LTD

0

Your Cart